The pathological biomarkers detected validated that a paranuclear “dot-like pattern” of CD99 may be a useful biomarker to distinguish SPTP from PNET,12,13 whereas the nuclear accumulation of β-catenin and loss of E-cadherin expression was obvious in SPTP specimens. This evidence concerns the gene CD99 and primitive neuroectodermal tumor.